Composition Cagrilintide: 5mg GLP-1 S: 5 mg Fill volume: 2 ml vial Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined pathway evaluation of amylin-receptorrelated and GLP-1receptor mechanisms in in-vitro or ex-vivo models Assay development, including chromatographic separation of two co-formulated peptides and blend ratio characterization Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing COA pending third-party verification in progress Lyophilized for transit stability
If you have been prescribed Semax and want to know precisely how to use it, or if you are evaluating whether Semax belongs in your next protocol, this is the reference you need
Clinical trials and approved ACPs The therapeutical utility of therapeutic peptides is straightforward because only in the USA were nearly 140 clinical trials registered to evaluate the eligibility of peptides for cancer treatment
According to the Handbook of Clinical Neurology , lumbar stenosis has an incidence of five cases per 100,000, compared to an incidence of one case per 100,000 for cervical stenosis
,aspect=ignore)
